Us Bancorp \De\ Epizyme, Inc. Transaction History

Us Bancorp \De\

  • $77.3 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.42 - $1.48 $649 - $2,289
-1,547 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$1.06 - $2.68 $2,040 - $5,159
-1,925 Reduced 55.44%
1,547 $2,000
Q4 2021

Feb 11, 2022
BUY
$2.5 - $5.19 $887 - $1,842
355 Added 11.39%
3,472 $8,000
Q3 2021

Nov 10, 2021
BUY
$4.82 - $8.46 $4,000 - $7,021
830 Added 36.29%
3,117 $16,000
Q2 2021

Aug 05, 2021
BUY
$6.81 - $9.71 $4,569 - $6,515
671 Added 41.52%
2,287 $19,000
Q1 2021

Apr 28, 2021
BUY
$7.45 - $12.32 $3,657 - $6,049
491 Added 43.64%
1,616 $14,000
Q3 2020

Nov 10, 2020
BUY
$11.73 - $16.25 $13,196 - $18,281
1,125 New
1,125 $14,000

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email